POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial

BACKGROUND: Postoperative chemotherapy is a standard treatment for stage II and III gastric cancer in Asia. With regard to single-agent or doublet, the need for improvement has consistently been pointed out because of the relatively poor outcome for patients with stage III gastric cancer. Triplet ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Liyu, Zhao, Shen, Yin, Yi, Huang, Feng, Zhu, Jinfeng, Chen, Luchuan, Lin, Rongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380469/
https://www.ncbi.nlm.nih.gov/pubmed/35983099
http://dx.doi.org/10.3389/fmed.2022.861777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380469/
https://www.ncbi.nlm.nih.gov/pubmed/35983099
http://dx.doi.org/10.3389/fmed.2022.861777

Ejemplares similares